Results 191 to 200 of about 12,905,954 (250)
Abstract Aims HNF1B variants cause autosomal dominant tubulointerstitial kidney disease (ADTKD‐HNF1B), but the phenotypic spectrum of variants of uncertain significance (VUS) remains incompletely defined. We aimed to characterise the multisystem phenotype associated with the HNF1B p.E105K variant and to examine the mechanism underlying insulin ...
YunZe Wang +5 more
wiley +1 more source
New insights into β‐cell vulnerability in type 1 diabetes—Lessons from nature
Abstract Type 1 diabetes results from an autoimmune‐mediated destruction of pancreatic β‐cells, yet considerable heterogeneity exists regarding disease onset, progression and severity. Emerging evidence suggests that this variability reflects not only differences in immune responses, but also differences in the architecture and immune landscape of the ...
Kathryn Murrall +10 more
wiley +1 more source
Dental resin composites generate microparticles and impact on gingival keratinocytes—In vitro study
Abstract Along with our increased understanding of the spread of microplastic pollution, the awareness of microparticle release from medical and dental materials has increased. Still, their effects on human health are largely unknown. As the use of resin composite materials in dentistry continues to increase, it is essential to understand the formation
Ella Pullinen +4 more
wiley +1 more source
Abstract This randomized crossover in vivo study compared the anti‐erosive efficacy of solution and orodispersible film (ODF) formulations containing three cystatins (CaneCPI‐5, MaquiCPI‐3, and CsinCPI‐2) combined with a statherin‐derived peptide (StN15pSpS).
Marília Afonso Rabelo Buzalaf +12 more
wiley +1 more source
Tankyrase‐2 regulates adipocyte differentiation through AMPK/mTOR signaling
Tankyrase 2 (TNKS2), a PARP family member, underpins adipocyte differentiation. TNKS2 controls LKB1 protein level, and consequently, the activity of the mTOR/AMPK system and adipocyte differentiation through a layered process. Pharmacological inhibition of TNKS2 leaves other PARPs and DNA repair active and therefore represents a novel target in ...
Boglarka Rauch +7 more
wiley +1 more source
FTO regulates mRNA stability and translational efficiency through its m6A‐demethylation activity. GSK3 functions as an upstream regulator of FTO, leading to its inhibition via phosphorylation. In male germ cells, FTO activity is kept in check by GSK3α.
Neha Choudhari +7 more
wiley +1 more source
LbAha1 activates LbHsp90 through a multistep mechanism in which productive N‐domain docking precedes ATP‐driven rearrangement and linker ordering. The LbAha1 linker transitions from a flexible to helical state, stabilizing an asymmetric, catalytically competent closed complex.
Paulo Roberto Dores‐Silva +9 more
wiley +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Recombinant human growth hormone.
Clinics in endocrinology and metabolism, 1986All batches of Met-hGH examined stimulated statural growth to approximately the same extent. The growth rates measured partly exceeded the results obtained in previous studies with pituitary preparations in the same dosage. Under treatment with SI, i.e.
L M, Fryklund, J R, Bierich, M B, Ranke
openaire +2 more sources
NAEVOCYTE TRIGGERING BY RECOMBINANT HUMAN GROWTH HORMONE
The Journal of Pathology, 1996The influence of growth hormone and insulin-like growth factor I on human melanocytes is being increasingly recognized. Clinical evidence has shown that when recombinant human growth hormone (hGH) is administered to children of short stature, the growth of melanocytic naevi is boosted. This study was conducted on 56 hGH-triggered naevi and nine similar
Pierard, Gérald +5 more
openaire +3 more sources
Recombinant human growth hormone and Gitelman's syndrome
American Journal of Kidney Diseases, 1999Gitelman's syndrome is a primary renal tubular disorder with hypokalemic metabolic alkalosis, hypocalciuria, and magnesium deficiency. Short stature is one of clinical manifestations in children. The pathogenesis of short stature in Gitelman's syndrome is not known.
C W, Ko, J H, Koo
openaire +2 more sources

